fentribal
Postman
- Joined
- Mar 25, 2016
- Messages
- 548
I'm not sure that not being the chairman of the board necessarily means you can't have vested interest and the point about risking damage to the brand, whether it be financial or reputationally, has been taken out of the equation when you have been told that there is no legal responsibility for any detrimental effects and to just get it out and into the population double-quick. So in effect, If your product works, you are the savior of mankind and you make shed loads of money and on the flip side if it doesn't work and has any sort of negative effect, no damage to reputation because at least have had a go working in the boundaries you had been given, and so you still make shed loads lot of money. The stories that surface like the one about Matt Hancock and his sister's company, and the large stake he owns in it, are only ever I fear going to be the tip of the iceberg.Doesn't matter where it came from, my point is the 100 day target is absolutely nothing new and in this respect - along with most of the others - it's meaningless. Just gives the media something to help fill the 24 hr news cycle. The big pharmaceutical companies are not state owned. Boris and his G7 pals can say whatever they like. Sounds nice to some, not so nice to others, but it ain't worth a damn when all is said and done.
As I just posted above; big pharma isn't state owned. Hancock isn't chairman of board. BJ&Co don't dictate drug development time frames which is incredibly unpredictable. They can certainly help fund it but big pharma will pay an enormous financial and reputational price if they were to let political considerations dictate their agendas.
IMHO.
I too, with all my heart, would love to honestly believe that every decision currently being made and action that is being taken, is for the good of humanity and for no other reason, but I just can't bring myself to do it.